Olmesartan Hexal (Olmesartan Medoxomil)

Olmesartan medoxil, the active ingredient in Olmesartan Hexal, is a angiotensin II receptor blocker presented as a tablet for oral use. It is employed in the management of hypertension in adult patients. GNH USA supplies Olmesartan Hexal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmesartan Hexal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olmesartan Hexal is an angiotensin‑II receptor blocker indicated for conditions affecting the renin‑angiotensin system.

- Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Heart failure: used as part of combination therapy to improve symptoms and outcomes. - Diabetic nephropathy: helps slow progression of kidney damage associated with diabetes.

Adverse reactions to olmesartan may vary in frequency and severity.

Common Side Effects: - Dizziness - Headache - Fatigue - Nasal congestion - Diarrhea - Cough

Serious or Rare Side Effects: - Angio‑angina   - Hyperkalemia - Acute kidney injury - Severe hypotension - Liver enzyme elevation - Bullous skin reactions

Olmesartan Hexal should be used with caution:

- Renal impairment: adjust dosing and monitor kidney function. - Hepatic impairment: use with care. - Electrolyte disturbances: monitor serum potassium. - Pregnancy: contraind  - Breastfeeding: unknown  - Store at below   -  

--- ---